Skip to content
healthcare.dev

Cetirizine Hydrochloride

NDC 55289-995, Cetirizine Hydrochloride, tablet, from PD-Rx Pharmaceuticals, Inc..

Product NDC
55289-995
Status
Listed
Labeler
PD-Rx Pharmaceuticals, Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
ANDA
Application
ANDA077498
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/55289-995 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CETIRIZINE HYDROCHLORIDE10 mg/1

Pharmacologic classes

Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Antagonist [EPC]

Package NDCNDC-11Package
55289-995-07552890995077 TABLET in 1 BOTTLE, PLASTIC (55289-995-07)
55289-995-105528909951010 TABLET in 1 BOTTLE, PLASTIC (55289-995-10)
55289-995-305528909953030 TABLET in 1 BOTTLE, PLASTIC (55289-995-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 55289-995 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/55289-995 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 55289-995. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.